NAA10 and rheumatoid arthritis: Although MAA adducts and anti-MAA antibodies appear to promote inflammation, bone erosion, and/or fibrosis in RA, no clinical or pre-clinical study to date has evaluated whether pharmacological inhibition of MAA can attenuate RA disease progression.